Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes

被引:24
作者
Dikicioglu, E
Barutca, S [1 ]
Meydan, N
Meteoglu, I
机构
[1] Adnan Menderes Univ, Sch Med, Dept Med Oncol, TR-09100 Aydin, Turkey
[2] Adnan Menderes Univ, Sch Med, Dept Pathol, TR-09100 Aydin, Turkey
关键词
breast cancer; metastasis; oestrogen receptor; progesterone receptor; Ki-67; HER-2/neu; p53;
D O I
10.1111/j.1742-1241.2005.00546.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diminished oestrogen receptor (ER) expression in the involved axillary lymph nodes (ALN) in breast cancer compared with the primary turnout has been reported in previous studies. We have assessed a wider spectrum of turnout markers (ER, progesterone receptor (PgR), p53, Ki-67 and HER-2/ neu) and compared extent and staining intensities at the primary turnout and the involved ALN on specimens of 22 cases with invasive ductal breast cancer. At the involved ALN, both the quantity of positive staining cells and the staining intensities for ER and PgR were decreased (p < 0.001 and p = 0.003, respectively). In contrast, the quantity of positive staining cells (p < 0.004) and the staining intensities for Ki-67 were increased. The differences for HER-2/neu and p53 staining at both sites were insignificant. The immunohistochemical staining properties of both the primary turnout and the ALN metastases showed no correlation with the number of involved ALN (p > 0.05). This study suggested that ALN metastasis might indicate a more unfavourable expression pattern of ER, PgR and Ki-67 in invasive ductal breast cancer.
引用
收藏
页码:1039 / 1044
页数:6
相关论文
共 31 条
[1]  
Barbour A, 2003, ANN ACAD MED SINGAP, V32, P176
[2]  
Beenken S W, 2002, Minerva Chir, V57, P437
[3]  
Blackwood M. Anne, 1996, Current Opinion in Oncology, V8, P449
[4]   Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor [J].
Buxant, F ;
Anaf, V ;
Simon, P ;
Fayt, I ;
Noël, JC .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 75 (01) :1-3
[5]   HETEROGENEITY OF SOLUBLE AND NUCLEAR ESTROGEN-RECEPTOR STATUS OF INVOLVED NODES IN RELATION TO PRIMARY BREAST-CANCER [J].
CASTAGNETTA, L ;
TRAINA, A ;
DICARLO, A ;
LATTERI, AM ;
CARRUBA, G ;
LEAKE, RE .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (01) :31-35
[6]   THE PROGNOSIS OF BREAST-CANCER PATIENTS IN RELATION TO THE ESTROGEN-RECEPTOR STATUS OF BOTH PRIMARY DISEASE AND INVOLVED NODES [J].
CASTAGNETTA, L ;
TRAINA, A ;
CARRUBA, G ;
FECAROTTA, E ;
PALAZZOTTO, G ;
LEAKE, R .
BRITISH JOURNAL OF CANCER, 1992, 66 (01) :167-170
[7]  
CHANG J, 2002, ENDOCRINE THERAPY BR, P33
[8]  
CHARPIN C, 1988, CANCER RES, V48, P4368
[9]  
Conti F, 2003, Tumori, V89, P181
[10]   Pathology of breast carcinoma [J].
D'arrigo, C ;
Fentiman, IS .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (01) :29-34